- Home
- ZLAB vs FBP Comparison
ZLAB vs FBP Comparison
Compare ZLAB & FBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZLAB
- FBP
- Stock Information
- Founded
- ZLAB 2013
- FBP 1948
- Country
- ZLAB China
- FBP United States
- Employees
- ZLAB N/A
- FBP N/A
- Industry
- ZLAB Biotechnology: Pharmaceutical Preparations
- FBP Major Banks
- Sector
- ZLAB Health Care
- FBP Finance
- Exchange
- ZLAB Nasdaq
- FBP Nasdaq
- Market Cap
- ZLAB 3.6B
- FBP 3.4B
- IPO Year
- ZLAB 2017
- FBP N/A
- Fundamental
- Price
- ZLAB $32.54
- FBP $22.06
- Analyst Decision
- ZLAB Buy
- FBP Buy
- Analyst Count
- ZLAB 5
- FBP 3
- Target Price
- ZLAB $54.28
- FBP $24.00
- AVG Volume (30 Days)
- ZLAB 782.4K
- FBP 1.1M
- Earning Date
- ZLAB 08-05-2025
- FBP 07-22-2025
- Dividend Yield
- ZLAB N/A
- FBP 3.30%
- EPS Growth
- ZLAB N/A
- FBP 4.49
- EPS
- ZLAB N/A
- FBP 1.84
- Revenue
- ZLAB $418,326,000.00
- FBP $884,832,000.00
- Revenue This Year
- ZLAB $44.07
- FBP $2.26
- Revenue Next Year
- ZLAB $49.13
- FBP $6.94
- P/E Ratio
- ZLAB N/A
- FBP $11.97
- Revenue Growth
- ZLAB 43.72
- FBP 2.45
- 52 Week Low
- ZLAB $16.01
- FBP $16.40
- 52 Week High
- ZLAB $44.34
- FBP $22.40
- Technical
- Relative Strength Index (RSI)
- ZLAB 40.19
- FBP 70.37
- Support Level
- ZLAB $34.26
- FBP $21.60
- Resistance Level
- ZLAB $35.72
- FBP $22.09
- Average True Range (ATR)
- ZLAB 1.12
- FBP 0.44
- MACD
- ZLAB -0.54
- FBP 0.12
- Stochastic Oscillator
- ZLAB 3.83
- FBP 98.82
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.
About FBP First BanCorp. New
First BanCorp is a financial holding company. The company's operating segment includes Commercial and Corporate Banking; Mortgage Banking; Consumer (Retail) Banking; Treasury and Investments; United States Operations; and Virgin Islands Operations. It generates maximum revenue from the Consumer (Retail) Banking segment. The Consumer (Retail) Banking segment generates majority revenue, which consists of the Corporation's consumer lending and deposit-taking activities conducted mainly through its branch network and loan centres. Geographically, it derives a majority of revenue from Puerto Rico.